The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to accelerate ...
Adderall is a central nervous system stimulant that's prescribed to treat two conditions, attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. If you're ...
Share on Pinterest The FDA recently approved a generic abortion pill that’s considered as safe and effective as mifepristone. Shuran Huang for The Washington Post via Getty Images The approval, ...
The Food and Drug Administration on Tuesday quietly approved a generic form of mifepristone, one of the two medications used in most U.S. abortions. That makes the drug, from the company Evita ...
The decision enraged opponents of abortion, who have been pressuring the Trump administration to restrict access to abortion medication. By Pam Belluck The Food and Drug Administration has approved a ...
Adderall is a central nervous system stimulant that's prescribed to treat two conditions, attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. If you're ...
Google Tables, a work-tracking tool and competitor to the popular spreadsheet-database hybrid Airtable, is shutting down. In an email sent to Tables users this week, Google said the app will not be ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. For the first time, a generic GLP-1 has been approved by ...
As much as we hate to admit it — we’re approaching the last days of summer. Luckily, there are opportunities to bid the season farewell with dining experiences that celebrate Michigan’s bounty.
GSK expands Medicines Patent Pool deal to allow generic production of cabotegravir for HIV treatment
GSK has expanded its voluntary licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) for cabotegravir, allowing it to be produced by three generic drugmakers and supplied to ...
President Trump signed an executive order aiming to reduce the price of prescription drugs. WSJ’s Jared Hopkins explains what we know about the plan. Photo: Chris Kleponis/Press Pool; Shutterstock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results